E

Ezintsha | Wits Health Consortium

Research site
(Unclaimed)
Location
32 Princess of Wales Terrace Building C, Ground Floor, Johannesburg, Guateng, South Africa
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

3 of 7
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Safety, Tolerability, and Immunogenicity Study of mRNA-1345 and mRNA-1365 in Participants Aged 5 Months to <24 Months

The purpose of this study is to assess the safety and immunogenicity of mRNA-1365, an mRNA vaccine targeting respiratory syncytial virus (RSV) and hu...

Active, not recruiting
Human Metapneumovirus
Respiratory Syncytial Virus
Biological: Placebo
Biological: mRNA-1345
Locations recently updated

Semaglutide is a medicine studied in patients with NASH. Semaglutide is a well-known medicine, which is already used by doctors to treat type 2 diabe...

Enrolling
Non-alcoholic Steatohepatitis
Drug: Placebo
Drug: Semaglutide

The goal of this clinical study is to learn more about the effects of switching to the study drugs, bictegravir (BIC) plus lenacapavir (LEN), versus...

Enrolling
HIV-1-infection
Drug: Bictegravir
Drug: BIC/LEN FDC

Trial conditions

COVID-19 (3 trials)
Fatty Liver (1 trial)
Non-alcoholic Fatty Live... (1 trial)
Pulmonary Tuberculosis (1 trial)
Respiratory Tract Infect... (1 trial)
Severe Acute Respiratory... (1 trial)
Syndrome (1 trial)
Tuberculosis (1 trial)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems